490 related articles for article (PubMed ID: 30862720)
41. Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-κB signaling axis.
Baik IH; Jo GH; Seo D; Ko MJ; Cho CH; Lee MG; Lee YH
Int J Oncol; 2016 Nov; 49(5):1953-1962. PubMed ID: 27633352
[TBL] [Abstract][Full Text] [Related]
42. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
43. Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑κB signaling pathway.
Jiang T; Li H; Jiang R; Li H; Hou P; Chen Y; Bai J; Song J
Oncol Rep; 2018 Sep; 40(3):1533-1544. PubMed ID: 30015978
[TBL] [Abstract][Full Text] [Related]
44. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
45. 8-Acetonyldihydronitidine inhibits the proliferation of human colorectal cancer cells via activation of p53.
Zhou J; Li Z; Zhang J; Wang H; Yin S; Du J
Eur J Pharmacol; 2019 Jul; 854():256-264. PubMed ID: 30928633
[TBL] [Abstract][Full Text] [Related]
46. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
47. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
48. EXOSC8 promotes colorectal cancer tumorigenesis via regulating ribosome biogenesis-related processes.
Cui K; Gong L; Zhang H; Chen Y; Liu B; Gong Z; Li J; Wang Y; Sun S; Li Y; Zhang Q; Cao Y; Li Q; Fei B; Huang Z
Oncogene; 2022 Dec; 41(50):5397-5410. PubMed ID: 36348012
[TBL] [Abstract][Full Text] [Related]
49. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
[TBL] [Abstract][Full Text] [Related]
50. TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome.
Zhao P; Pang X; Jiang J; Wang L; Zhu X; Yin Y; Zhai Q; Xiang X; Feng F; Xu W
Carcinogenesis; 2019 Jun; 40(4):592-599. PubMed ID: 30445600
[TBL] [Abstract][Full Text] [Related]
51. PDRG1 predicts a poor prognosis and facilitates the proliferation and metastasis of colorectal cancer.
Xu Y; Liu J; Jiang T; Shi L; Shang L; Song J; Li L
Exp Cell Res; 2021 Dec; 409(2):112924. PubMed ID: 34780783
[TBL] [Abstract][Full Text] [Related]
52. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
53. Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer.
Bi J; Huang A; Liu T; Zhang T; Ma H
Int J Clin Exp Pathol; 2015; 8(6):6070-82. PubMed ID: 26261485
[TBL] [Abstract][Full Text] [Related]
54. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
[TBL] [Abstract][Full Text] [Related]
55. The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival.
Shen J; Li P; Shao X; Yang Y; Liu X; Feng M; Yu Q; Hu R; Wang Z
Cancer Res; 2018 Jan; 78(2):359-371. PubMed ID: 29187402
[TBL] [Abstract][Full Text] [Related]
56. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
Zhang S; Li J; Wang X
Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614
[TBL] [Abstract][Full Text] [Related]
57. Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway.
Guo X; Li Y; Chen X; Sun B; Guo X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):163. PubMed ID: 38546882
[TBL] [Abstract][Full Text] [Related]
58. Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
Yan X; Huang L; Liu L; Qin H; Song Z
Cancer Med; 2018 Feb; 7(2):420-432. PubMed ID: 29341479
[TBL] [Abstract][Full Text] [Related]
59. The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.
Zheng HC; Liu JJ; Li J; Wu JC; Yang L; Zhao GF; Zhao X; Jiang HM; Huang KQ; Li ZJ
Oncotarget; 2017 Apr; 8(14):23603-23612. PubMed ID: 28223542
[TBL] [Abstract][Full Text] [Related]
60. Functional role of RRS1 in breast cancer cell proliferation.
Song J; Ma Z; Hua Y; Xu J; Li N; Ju C; Hou L
J Cell Mol Med; 2018 Dec; 22(12):6304-6313. PubMed ID: 30320499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
